[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368846-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368846-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ursolic-acid-a-natural-pentacyclic-triterpenoid-with-clinical-promise-in-gynecological-and-breast-cancers-review","Ursolic acid: A natural pentacyclic triterpenoid with clinical promise in gynecological and breast cancers (Review)","","Gynecological and breast cancers continue to drive substantial cancer-related morbidity and mortality, despite progress in screening, diagnosis, and treatment. Ursolic acid (UA), a naturally occurring pentacyclic triterpenoid from plants, is highlighted for its broad pharmacological profile including antitumor, anti-inflammatory, and antioxidant activities. Mechanistic evidence indicates that UA can suppress tumor proliferation, promote apoptosis, reverse chemoresistance, and alter cancer stem cell traits through pathways such as PI3K/AKT, NF-κB, and Wnt/β-catenin, and may improve outcomes and reduce chemotherapy-associated adverse effects when combined with agents like cisplatin or doxorubicin.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ursolic-acid-a-natural-pentacyclic-triterpenoid-with-clinical-promise-in-gynecological-and-breast-cancers-review/368846/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ursolic-acid-a-natural-pentacyclic-triterpenoid-with-clinical-promise-in-gynecological-and-breast-cancers-review/368846.png","ImageObject",300,407,{"name":42,"@type":43},"Franzy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is ursolic acid (UA) and why is it of interest for gynecological and breast cancers?","Question",{"text":63,"@type":64},"UA is a naturally occurring pentacyclic triterpenoid widely present in plants. It is highlighted for antitumor activity along with other pharmacological effects such as anti-inflammatory and antioxidant properties.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which signaling pathways are implicated in UA’s anticancer effects?",{"text":68,"@type":64},"UA is described as exerting anticancer effects by modulating multiple pathways including PI3K/AKT, NF-κB, and Wnt/β-catenin.",{"name":70,"@type":61,"acceptedAnswer":71},"How might UA be used alongside chemotherapy, and what potential benefit is mentioned?",{"text":72,"@type":64},"When combined with chemotherapeutic agents such as cisplatin and doxorubicin, UA is reported to enhance antitumor efficacy and mitigate chemotherapy-related adverse effects.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368846,1790810266,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":124,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336478945519,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","ONCOLOGY REPORTS 54: 153, 2025  \nUrsolic acid: A natural pentacyclic triterpenoid with clinical promise in gynecological and breast cancers (Review)  \nTINGTING CHEN, SHIRUN SUN, ZHENGLI ZHOU and XIUQIN ZHANG  \nJimo District Qingdao Hospital of Traditional Chinese Medicine, Qingdao, Shandong 266200, P.R. China  \nReceived May 26, 2025; Accepted September 2, 2025  \nDOI: 10. 3892/or.2025.8986  \nAbstract. Gynecological and breast cancers pose significant challenges to women's health worldwide. Despite notable advancements in diagnosis and treatment, they remain leading causes of cancer‑related mortality. Ursolic acid (UA), a naturally occurring pentacyclic triterpenoid widely found in plants, has garnered considerable attention due to its diverse pharmacological activities. It has been demonstrated that UA exhibits a range of biological effects, including antitumor, anti‑inflammatory, and antioxidant properties, with particularly promising therapeutic potential in breast and gynecological cancers . UA exerts its anticancer effects by modulating multiple signaling pathways, such as PI3K/AKT, NF‑κB, and Wnt/β‑catenin, thereby effectively inhibiting tumor cell proliferation, inducing apoptosis, reversing chemoresistance, and suppressing cancer stem cell characteristics . When combined with chemotherapeutic agents such as cisplatin and doxorubicin, UA not only enhances antitumor efficacy but also mitigates the adverse effects associated with chemotherapy. The present review summarizes the recent research progress and underlying mechanisms of UA in the treatment of gyneco‑ logical and breast cancers, aiming to provide valuable insights for researchers and clinicians in the field.  \nContents  \n1. Introduction  \n2. Structural properties, natural origins and extraction methods of UA  \n3. Anticancer mechanisms of UA in gynecological and breast cancers  \n4. Advances in drug delivery strategies and derivatives of UA  \n5. Challenges and future perspectives  \nCorrespondence to: Dr Xiuqin Zhang, Jimo District Qingdao Hospital of Traditional Chinese Medicine, 1281 Aolan Road, Qingdao, Shandong 266200, P.R. China  \nE‑mail: [qdtcm1313@163.com](qdtcm1313@163.com)  \nKey words: gynecological cancers, breast cancer, ursolic acid, natural compounds, mechanisms  \n1. Introduction  \nGynecological malignancies represent a major threat to women's health. According to data from the International Agency for Research on Cancer in 2020, there are ~1.33 million new cases and 540,000 deaths related to gynecological cancers worldwide each year (1,2) . Cervical, endometrial and ovarian cancers are the three most common malignancies of the female reproductive system and, together with breast cancer, constitute a substantial global health burden for women, accounting for nearly one‑third of all cancer‑related incidence and mortality among female patients (3) . Despite significant progress in screening, diagnosis and treatment, these malig‑ nancies remain leading causes of female cancer‑related deaths due to their biological heterogeneity, late‑stage diagnosis and therapeutic resistance (4,5) . Breast cancer is the most prevalent malignancy in women. Molecular subtyping‑such as estrogen/progesterone receptor (ER /PR)‑positive, HER2‑enriched, and triple‑negative breast cancer (TNBC)‑has led to breakthroughs in targeted therapies, including CDK4/6 inhibitors and anti‑HER2 agents (6). However, the management of metastatic disease and the emergence of drug resistance continue to pose major challenges . Among gynecological cancers, ovarian cancer has the highest mortality rate due to its asymptomatic nature and frequent diagnosis at an advanced stage (7) . Recent advances, such as PARP inhibitors for BRCA‑mutated tumors and immunotherapy, have redefined treatment strategies, yet the high recurrence rate underscores the urgent need for novel biomarkers (8) . Endometrial cancer has traditionally been associated with obesity and metabolic disorders, and molecular subtypes iden","cbCailAQ2GybZAv4","https://ap.wps.com/l/cbCailAQ2GybZAv4","pdf",1878016,"English","# Introduction\n## Structural properties, natural origins and extraction methods of UA\n## Anticancer mechanisms of UA in gynecological and breast cancers\n## Advances in drug delivery strategies and derivatives of UA\n## Challenges and future perspectives","[{\"question\":\"What is ursolic acid (UA) and why is it of interest for gynecological and breast cancers?\",\"answer\":\"UA is a naturally occurring pentacyclic triterpenoid widely present in plants. It is highlighted for antitumor activity along with other pharmacological effects such as anti-inflammatory and antioxidant properties.\"},{\"question\":\"Which signaling pathways are implicated in UA’s anticancer effects?\",\"answer\":\"UA is described as exerting anticancer effects by modulating multiple pathways including PI3K/AKT, NF-κB, and Wnt/β-catenin.\"},{\"question\":\"How might UA be used alongside chemotherapy, and what potential benefit is mentioned?\",\"answer\":\"When combined with chemotherapeutic agents such as cisplatin and doxorubicin, UA is reported to enhance antitumor efficacy and mitigate chemotherapy-related adverse effects.\"}]","Ursolic acid: A natural pentacyclic triterpenoid with clinical promise in gynecological and breast cancers (Review) | PDF",1790178912,25,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2cf7885f02bf6158e9e1f0aa548ef7ab.webp",983,1357,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f416263dd373833cfff2effb73450374.webp",982,1356,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67c5f721d028fb03f768552e923b10a9.webp",981,1354,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6fabef0cb56c064318f56bef6b78de9b.webp",980,1353]